Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Market Insights | Latin America | 2025

The Latin American IC device market has recovered from the COVID-19 pandemic and is reverting to prepandemic growth trends. Increasing patient pool, launch of newer generation devices and increasing penetration of PCIs have supported the IC device space and will continue to do so over the forecast period. In addition, premium-priced advanced technologies have started seeing strong uptake and are expected to change existing treatment algorithms, thus disrupting the established category leaders.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IC devices in the Latin American region from 2019 through 2033.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Interventional Cardiology Devices – Market Insights – Latin America
The Latin American IC device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Latin America (Supplemental)
The Latin American EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Latin American countries, improved…
Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectable market is expected to experience rapid growth through 2034. This expansion will be driven by product development and differentiation efforts from market…
Report
Biosurgical Agents – Market Insights – Latin America (Supplemental)
The biosurgical agent market in Latin America will observe modest growth through 2033, primarily driven by the increasing number of procedures utilizing biosurgical agents, combined with favorable…